Nesidioblastosis and hyperplasia of α cells, microglucagonoma, and nonfunctioning islet cell tumor of the pancreas: Review of the literature

Pancreas

Volumn 36, Issue 4, 2008, Pages 428-431

  Yu, Run ^a   Nissen, Nicholas N ^a,b   Dhall, Deepti ^a   Heaney, Anthony P ^b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cells; Glucagon; Hyperplasia; Islet cell tumor; Nesidioblastosis; Somatostatin analog

Indexed keywords

GLUCAGON; OCTREOTIDE; SOMATOSTATIN DERIVATIVE;

ADULT; ARTICLE; CASE REPORT; CELL HYPERPLASIA; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; FEMALE; FOLLOW UP; GLUCAGON BLOOD LEVEL; GLUCAGON RELEASE; GLUCAGONOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INSULINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET CELL TUMOR; PANCREATICODUODENECTOMY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; TUMOR RECURRENCE;

ADENOMA, ISLET CELL; ADULT; CARCINOMA, ISLET CELL; FEMALE; GLUCAGONOMA; HUMANS; HYPERPLASIA; ISLETS OF LANGERHANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NESIDIOBLASTOSIS; PANCREATIC NEOPLASMS;

EID: 42549138804     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e31815ceb23     Document Type: Article

References (14)

1. Cummings DE. Gastric bypass and nesidioblastosis - too much of a good thing for islets? N Engl J Med. 2005;353:300-302.
2. Delonlay P, Simon A, Galmiche-Rolland L, et al. Neonatal hyperinsulinism: clinicopathologic correlation. Hum Pathol. 2007;38:387-399.
3. Witteles RM, Straus FH II, Sugg SL, et al. Adult-onset nesidioblastosis causing hypoglycemia: an important clinical entity and continuing treatment dilemma. Arch Surg. 2001;136:656-663.
4. Thompson G. Diffuse nesidioblastosis as a cause of hyperinsulinemic hypoglycemia in adults: a diagnostic and therapeutic challenge. Surgery. 2007;141:185-186.
5. Patti ME, McMahon G, Mun EC, et al. Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia. 2005;48:2236-2240.
6. Service GJ, Thompson GB, Service FJ, et al. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med. 2005;353:249-254.
7. Balas D, Senegas-Balas F, Delvaux M, et al. Silent human pancreatic glucagonoma and BA[ nesidioblastosis. Pancreas. 1988;3:734-739.
8. Martignoni ME, Kated H, Stiegler M, et al. Nesidioblastosis with glucagon-reactive islet cell hyperplasia: a case report. Pancreas. 2003;26:402-405.
9. Recant L, Perrino PV, Bhathena SJ, et al. Plasma immunoreactive glucagon fractions in four cases of glucagonoma: increased Blarge glucagon- immunoreactivity.[ Diabetologia. 1976;12:319-326.
10. Maton PN, Gardner JD, Jensen RT. Use of long-acting somatostatin analog SMS 201-995 in patients with pancreatic islet cell tumors. Dig Dis Sci. 1989;34:28S-39S.
11. Thompson NW, Lloyd RV, Nishiyama RH, et al. MEN I pancreas: a histological and immunohistochemical study. World J Surg. 1984;8:561-574.
12. Asgharian B, Chen YJ, Patronas NJ, et al. Meningiomas may be a component tumor of multiple endocrine neoplasia type 1. Clin Cancer Res. 2004;10:869-880.
13. Lubensky IA, Pack S, Ault D, et al. Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: histopathological and molecular genetic analysis. Am J Pathol. 1998;153:223-231.
14. Governale LS, Vortmeyer AO, Zhuang Z, et al. Fibrous meningioma in a patient with von Hippel-Lindau disease: a genetic analysis. J Neurosurg. 2001;95:1045-1049.